Surplus Solutions Acquires DCM BioServices

Northwest Biotherapeutics Acquires Advent BioServices (DCVax Manufacturing Scale-Up)

October 26, 2025

Biotechnology

Northwest Biotherapeutics (NWBio) has completed its acquisition of Advent BioServices Ltd., with Advent becoming a wholly owned subsidiary. The deal is intended to create a more integrated manufacturing and operations platform to scale production of NWBio’s DCVax immunotherapy products, including facilitating consolidation of facilities and reallocation of resources to Sawston and capacity expansion in the United States.

Surplus Solutions (NMS Capital) Acquires Certified Genetool

April 7, 2025

Healthcare Services

Surplus Solutions LLC, an NMS Capital portfolio company, has acquired Certified Genetool, a San Francisco-based provider of certified and refurbished laboratory instruments and technical services. The add-on expands Surplus Solutions' refurbishment, resale and service capabilities—particularly in flow cytometry—and broadens its reach into academic, biotechnology and pharmaceutical end markets. Terms were not disclosed.

Aldaron Partners and True Wind Capital Acquire DCM Services

March 17, 2025

Professional Services

Aldaron Partners and True Wind Capital have partnered to acquire DCM Services, a Minneapolis-area leader in estate and specialty receivables recovery. The private equity-backed partnership will support DCMS's growth and scale its proprietary Probate Finder technology and outsourced account resolution services across financial services, healthcare and other end markets.

NMS Capital Recapitalizes Surplus Solutions LLC

December 6, 2022

Healthcare Services

NMS Capital has partnered with Surplus Solutions’ management in a recapitalization of Surplus Solutions LLC; terms were not disclosed. The investment will support geographic and inventory expansion, strategic M&A, and investments in infrastructure and operations to drive the company's next phase of growth; Twin Brook Capital provided debt financing.

DCN Dx Acquires Biomed Diagnostics

April 25, 2022

Healthcare Services

DCN Dx, a provider of point-of-use test development and commercialization, completed its acquisition of Biomed Diagnostics, a microbiological testing products company based in White City, Oregon. The deal expands DCN Dx’s footprint in point-of-use testing and sampling across both human and veterinary verticals.

NMS Capital Recapitalizes DCM Services

February 25, 2020

Data & Analytics

NMS Capital has partnered with DCM Services' management in a recapitalization of DCM Services, a Minneapolis-area provider of data and contact management solutions for estate and specialty receivables recovery. The investment will support growth and scaling of DCM's proprietary Probate Finder technology, expand capabilities, and target growth across financial services, healthcare and other end markets.